ThiopurineS-methyltransferase genotype and the use of thiopurines in paediatric inflammatory bowel disease Greek patients
- 1 February 2010
- journal article
- Published by Hindawi Limited in Journal of Clinical Pharmacy and Therapeutics
- Vol. 35 (1) , 93-97
Abstract
Azathioprine (AZA) and 6-mercaptopurine (6MP) are used in the treatment of paediatric inflammatory bowel disease (IBD). Genetic variations in thiopurine S-methyltranfarase (TPMT) gene have been correlated with enzyme activity and with the occurrence of adverse events to AZA and 6MP. The aim of the present study was to investigate the frequency of the functional TPMT polymorphisms and their association with the occurrence of adverse events during azathioprine therapy in a paediatric IBD cohort. Ninety-seven thiopurine-treated paediatric IBD patients (41.24% boys and 58.76% girls) with a mean age 11.25 years (range 3-16), were assessed for TPMT polymorphisms and adverse events. Of the 97 patients enrolled in the study, 18 (18.56%) were heterozygous mutated; two (2.06%) were homozygous for a mutated TPMT gene. Ten patients (10.31%) developed adverse effects, and four of them (40%) had one of the variant alleles. In this small cohort of subjects, no association was found between TPMT polymorphisms and the occurrence of thiopurines-related adverse events.Keywords
This publication has 20 references indexed in Scilit:
- Should TPMT genotype and activity be used to monitor 6-mercaptopurine treatment in children with acute lymphoblastic leukaemia?Journal of Clinical Pharmacy and Therapeutics, 2007
- Three novel thiopurine S-methyltransferase allelic variants (TPMT*20, *21, *22) – association with decreased enzyme functionHuman Mutation, 2006
- Pharmacogenetics of thiopurine therapy in paediatric IBD patientsAlimentary Pharmacology & Therapeutics, 2006
- TPMT genotype and the use of thiopurines in paediatric inflammatory bowel diseaseDigestive and Liver Disease, 2005
- Review article: monitoring of immunomodulators in inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2005
- Thiopurine S‐methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2003
- High‐dose azathioprine in children with inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2003
- Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel diseaseGut, 2001
- Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemiaThe Journal of Pediatrics, 1991
- Classification of Inflammatory Bowel DiseaseScandinavian Journal of Gastroenterology, 1989